Unjha Formulations files FY26 annual results with BSE

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Unjha Formulations filed FY26 audited results with BSE on September 8, 2026
  • Financial statements cover the period ending March 31, 2026
  • AGM was held on August 14, 2026 to approve the accounts
  • No specific revenue or profit figures disclosed in this notice
powered bylight_fuzz_icon
50412168

*this image is generated using AI for illustrative purposes only.

Unjha Formulations submitted its audited financial statements for FY26 to the Bombay Stock Exchange on September 8, 2026. The filing includes the balance sheet, profit and loss account, and cash flow statement as of March 31, 2026.

The submission was made pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company held its Annual General Meeting on August 14, 2026, where these results were approved by shareholders.

Filing Details

Krutibhai Mayank Patel, Managing Director of Unjha Formulations, signed the submission letter. The document references scrip code 531762 and confirms that the XML file containing the financial data has been uploaded via the BSE listing portal.

No specific financial metrics such as revenue, net profit, or dividend declarations were disclosed in this particular regulatory communication. The filing serves primarily as a procedural notification of the availability of the full financial statements.

Historical Stock Returns for Unjha Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
+4.97%+23.16%+39.26%+66.35%+37.72%+273.15%

How are Unjha Formulations' FY26 revenue and net profit margins expected to compare with FY25 given the current competitive landscape in the dermatology and hair care segments?

Will the company announce any dividend payouts or share buyback plans in the upcoming investor presentations following the AGM?

What strategic initiatives is Unjha Formulations prioritizing for international expansion in key markets like the US and Europe for the next fiscal year?

Unjha Formulations shareholders approve FY26 results, appoint Krutiben Patel as MD

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Unjha Formulations Limited concluded its 32nd AGM on August 14, 2026, with shareholders approving the FY26 audited financials. Key governance changes included the reappointment of Chairperson Jashodaben S. Patel and the new appointment of Krutiben M. Patel as Managing Director for three years. Related party transactions for FY27 were also approved.

powered bylight_fuzz_icon
48235838

*this image is generated using AI for illustrative purposes only.

Unjha Formulations Limited ( Unjha Formulations ) shareholders approved the company’s audited financial statements for the fiscal year ended March 31, 2026, during its 32nd Annual General Meeting (AGM) held on August 14, 2026. The meeting, convened at the company’s registered office in Sidhpur, Gujarat, also resulted in the appointment of Krutiben M. Patel as Managing Director for a three-year term.

The AGM was declared open by Company Secretary Khushboo N. Patel after confirming the presence of quorum. All directors attended the proceedings. Ajay Parikh & Associates served as the secretarial auditors and scrutinizers for the votes cast via remote e-voting and during the physical meeting.

Key Resolutions Passed

The shareholders transacted the following businesses through remote e-voting and e-voting at the venue, in compliance with the Companies Act, 2013 and SEBI regulations:

Ordinary Resolutions:

  • Adoption of the audited financial statements for the year ended March 31, 2026.
  • Appointment of Jashodaben S. Patel (DIN 05201715) as a director in place of her retirement by rotation.

Special Resolutions:

  • Approval of related party transactions for the fiscal year 2026-27.
  • Appointment of Krutiben M. Patel as Managing Director for a term of three years.

Management Commentary

Jashodaben S. Patel, Chairperson, delivered the statement on the affairs of the company. Krutiben Patel, Managing Director, addressed questions raised by members regarding the resolutions. The voting process continued for an additional 15 minutes on the CDSL platform to allow remaining members to cast their votes. The meeting concluded at 11:40 am.

Detailed voting results, as required under Regulation 44(3) of the SEBI Listing Regulations, were submitted separately to the exchanges.

Historical Stock Returns for Unjha Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
+4.97%+23.16%+39.26%+66.35%+37.72%+273.15%

How is the appointment of Krutiben M. Patel as Managing Director expected to influence Unjha Formulations' strategic growth and operational efficiency over the next three years?

What specific growth initiatives or capital expenditure plans are implied by the approval of related party transactions for the fiscal year 2026-27?

Given the adoption of financials for FY 2026, what are the management's projected revenue and margin targets for the upcoming fiscal year amidst current pharmaceutical market dynamics?

More News on Unjha Formulations

1 Year Returns:+37.72%